Vericel Says US FDA Approves SBLA for Tissue Restoring Knee Repair Treatment - Shares Up Pre-Bell
Vericel Says US FDA Approves SBLA for Tissue Restoring Knee Repair Treatment - Shares Up Pre-Bell
Vericel公司称美国FDA批准了用于修复膝关节的组织恢复治疗的衍生生物制品许可申请(SBLA)-盘前股价上涨
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册